Concepts (73)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cell-Derived Microparticles | 1 | 2015 | 7 | 0.560 |
Why?
|
| Biological Specimen Banks | 1 | 2015 | 21 | 0.550 |
Why?
|
| Exosomes | 1 | 2015 | 97 | 0.490 |
Why?
|
| Ascorbic Acid | 5 | 2005 | 63 | 0.290 |
Why?
|
| RNA, Small Interfering | 4 | 2012 | 391 | 0.280 |
Why?
|
| Ovarian Neoplasms | 3 | 2015 | 303 | 0.260 |
Why?
|
| Drug Delivery Systems | 3 | 2011 | 182 | 0.200 |
Why?
|
| Chitosan | 2 | 2011 | 36 | 0.190 |
Why?
|
| Neoplasms | 5 | 2011 | 1033 | 0.150 |
Why?
|
| Nanoparticles | 2 | 2011 | 294 | 0.140 |
Why?
|
| Antioxidants | 3 | 2005 | 386 | 0.140 |
Why?
|
| Gene Silencing | 3 | 2011 | 143 | 0.140 |
Why?
|
| Receptor, EphB4 | 1 | 2015 | 3 | 0.140 |
Why?
|
| Erythropoietin | 1 | 2015 | 37 | 0.140 |
Why?
|
| Breast Neoplasms | 3 | 2015 | 1426 | 0.140 |
Why?
|
| Neoplasms, Glandular and Epithelial | 1 | 2012 | 40 | 0.110 |
Why?
|
| Mice, Nude | 4 | 2015 | 323 | 0.100 |
Why?
|
| Hydrogels | 1 | 2011 | 33 | 0.100 |
Why?
|
| Lipoproteins, HDL | 1 | 2011 | 43 | 0.100 |
Why?
|
| Cell Cycle Proteins | 1 | 2012 | 220 | 0.090 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2015 | 781 | 0.090 |
Why?
|
| Melanoma | 1 | 2011 | 91 | 0.090 |
Why?
|
| Oligopeptides | 1 | 2010 | 97 | 0.090 |
Why?
|
| Animals | 6 | 2015 | 14307 | 0.090 |
Why?
|
| Antineoplastic Agents | 4 | 2011 | 756 | 0.070 |
Why?
|
| Cell Line, Tumor | 4 | 2015 | 2128 | 0.070 |
Why?
|
| Humans | 11 | 2015 | 34853 | 0.070 |
Why?
|
| Orthomolecular Therapy | 1 | 2002 | 3 | 0.050 |
Why?
|
| Copper Sulfate | 1 | 2002 | 5 | 0.050 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2015 | 605 | 0.050 |
Why?
|
| Blotting, Western | 2 | 2015 | 834 | 0.050 |
Why?
|
| Mice | 4 | 2012 | 5668 | 0.050 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2011 | 242 | 0.050 |
Why?
|
| Female | 6 | 2015 | 19873 | 0.040 |
Why?
|
| Receptors, Erythropoietin | 1 | 2015 | 7 | 0.030 |
Why?
|
| STAT3 Transcription Factor | 1 | 2015 | 80 | 0.030 |
Why?
|
| Infusions, Intravenous | 2 | 2005 | 48 | 0.030 |
Why?
|
| Recombinant Proteins | 1 | 2015 | 485 | 0.030 |
Why?
|
| Injections, Intravenous | 2 | 2004 | 58 | 0.030 |
Why?
|
| Disease Progression | 1 | 2015 | 580 | 0.030 |
Why?
|
| Protein Binding | 1 | 2015 | 913 | 0.030 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2012 | 157 | 0.030 |
Why?
|
| HCT116 Cells | 1 | 2011 | 34 | 0.030 |
Why?
|
| Neoplasm Invasiveness | 1 | 2012 | 247 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2005 | 984 | 0.020 |
Why?
|
| Microspheres | 1 | 2011 | 45 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2015 | 1530 | 0.020 |
Why?
|
| Neoplasm Metastasis | 1 | 2011 | 211 | 0.020 |
Why?
|
| Receptors, Cell Surface | 1 | 2010 | 135 | 0.020 |
Why?
|
| Aged | 2 | 2015 | 6448 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2015 | 2333 | 0.020 |
Why?
|
| Neoplasm Proteins | 1 | 2010 | 203 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2012 | 1152 | 0.020 |
Why?
|
| Models, Biological | 1 | 2011 | 642 | 0.020 |
Why?
|
| Middle Aged | 2 | 2015 | 9642 | 0.020 |
Why?
|
| Young Adult | 1 | 2015 | 4012 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2011 | 1149 | 0.020 |
Why?
|
| Palliative Care | 1 | 2005 | 52 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 2005 | 142 | 0.020 |
Why?
|
| Clinical Protocols | 1 | 2003 | 34 | 0.010 |
Why?
|
| Virus Diseases | 1 | 2003 | 21 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 2005 | 195 | 0.010 |
Why?
|
| Bacterial Infections | 1 | 2003 | 44 | 0.010 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2005 | 209 | 0.010 |
Why?
|
| Anti-Infective Agents | 1 | 2003 | 62 | 0.010 |
Why?
|
| Neoplastic Stem Cells | 1 | 2003 | 74 | 0.010 |
Why?
|
| Pain | 1 | 2005 | 249 | 0.010 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2002 | 107 | 0.010 |
Why?
|
| Cell Division | 1 | 2002 | 296 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 2002 | 480 | 0.010 |
Why?
|
| Adult | 1 | 2015 | 11034 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2004 | 1349 | 0.010 |
Why?
|
| Male | 1 | 2004 | 18870 | 0.000 |
Why?
|